Evogene Ltd. (TLV:EVGN)
244.80
+2.10 (0.87%)
Apr 24, 2026, 1:44 PM IDT
Evogene Employees
Evogene had 52 employees as of December 31, 2025. The number of employees decreased by 65 or -55.56% compared to the previous year.
Employees
52
Change (1Y)
-65
Growth (1Y)
-55.56%
Revenue / Employee
236.22K ILS
Profits / Employee
-520.20K ILS
Market Cap
29.63M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 52 | -65 | -55.56% | 52 | 0 |
| Dec 31, 2024 | 117 | -25 | -17.61% | 117 | 0 |
| Dec 31, 2023 | 142 | 5 | 3.65% | 142 | 0 |
| Dec 31, 2022 | 137 | -4 | -2.84% | 137 | 0 |
| Dec 31, 2021 | 141 | 10 | 7.63% | 141 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bonus BioGroup | 37 |
| BioLineRx | 24 |
| Matricelf | 15 |
| XTL Biopharmaceuticals | 10 |
| Purple Biotech | 10 |
| Geffen Residence & Renewal | 6 |
| Can-Fite BioPharma | 5 |
| BioLight Life Sciences | 4 |
Evogene News
- 22 days ago - Evogene (EVGN) Faces Nasdaq Compliance Challenge Over Bid Price - GuruFocus
- 22 days ago - Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification - PRNewsWire
- 24 days ago - Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock - PRNewsWire
- 6 weeks ago - Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline - GuruFocus
- 6 weeks ago - Q4 2025 Evogene Ltd Earnings Call Transcript - GuruFocus
- 6 weeks ago - Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 - PRNewsWire
- 7 weeks ago - Evogene (EVGN) Focuses on Key Markets Following Strategic Shift - GuruFocus
- 7 weeks ago - Evogene Earnings Review: Q4 Summary - Benzinga